Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07336485Completed
Randomised trial of furosemide in nephrolithiasis (2 arms), sponsored by Ain Shams University. Primary endpoint: Proportion of patients with residual stone fragments greater than 2 mm. Started Jan 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07336485.